Profil
Mr. Max H.
Mitteregger is a Founder & Owner at Max Mitteregger Kapitalförvaltning AB. He is on the Board of Directors at Max Mitteregger Kapitalförvaltning AB.
He has about 25 years of experience working in the financial sector, including as a partner, one of the founders and Head of Equity Sales at ABG Sundal Collier and Head of Sales at Carnegie.
Aktive Positionen von Max Mitteregger
| Unternehmen | Position | Beginn |
|---|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Gründer | 24.11.2004 |
Galba Holding AB | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Max Mitteregger
| Unternehmen | Position | Ende |
|---|---|---|
| LIDDS AB | Direktor/Vorstandsmitglied | 02.07.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Finance |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galba Holding AB |
















